Cellular retinaldehyde-binding protein (CRALBP) 1 is a 36-kDa water soluble protein with a high affinity binding pocket for retinoids uniquely associated with vision, namely 11-cisretinal and 11-cis-retinol (1). Human CRALBP gene defects can either tighten or abolish retinoid interactions, which in turn can compromise substrate carrier interactions with 11-cis-retinol dehydrogenase and lead to several retinal pathologies (2). Targeted disruption of the CRALBP gene in mice impairs regeneration of both rod and cone visual pigments (3). These and other studies establish multiple functions for CRALBP in the retinal pigment epithelium (RPE), including roles as a major acceptor of 11-cis-retinol in the isomerization step of the rod visual cycle and as a facilitator of oxidation of 11-cis-retinol to 11-cis-retinal by 11-cis-retinol dehydrogenase (2-6). Ongoing proteomic studies support the existence of a RPE retinoid processing protein complex containing CRALBP (7). Direct CRALBP interactions have been demonstrated in vitro with 11-cis-retinol dehydrogenase (2) and with ERM (ezrin, radixin, moesin)-binding phosphoprotein 50 (EBP50), also known as sodium hydrogen exchanger regulator factor type 1 (NHERF-1) (8). Interactions with EBP50 have been suggested as a mechanism for localizing CRALBP to the apical RPE plasma membrane for export of 11-cis-retinal to the adjacent rod photoreceptor cells for visual pigment regeneration (8). The functions of CRALBP in tissues other than the RPE remain to be determined (i.e. in retinal Mü ller cells, ciliary epithelium, iris, cornea, pineal gland, and a subset of oligodendrocytes of the optic nerve and brain).To better understand CRALBP visual cycle functions, which require rapid association and dissociation of retinoid, we are characterizing the structure of the ligand binding pocket. Ligand interactions in CRALBP are non-covalent and previous structure-function studies (2, 9, 10) have implicated eight residues as possibly interacting with retinoid (Fig. 1). In this report, the interaction between human recombinant CRALBP and retinoid were characterized by mass spectrometry using hydrogen/deuterium exchange and photoaffinity labeling with 3-diazo-4-keto-11-cis-retinal (DK-11-cis-retinal). This photoaffinity analogue of 11-cis-retinal has previously been used to map the movement of ligand within rhodopsin following sensi-* This study was supported in part by National Institutes of Health Grants EY6603, EY14239, GM63020, a Research Center Grant from The Foundation Fighting Blindness, and funds from the Cleveland Clinic Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Tables I and II. ¶ This work was submitted in partial fulfillment of the requirements for a doctoral degree in chemistry from Cleveland State University. 1 The abbreviations used are: CRALBP, cellular retinaldehyde-binding protein; DK...